Evidence map›Paper›PMID 28539771›Full record

ArticleEye and brain2010

Differential effects of amyloid-β peptide aggregation status on

H R Watts, Pjb Anderson, D Ma, K L Philpott, S M Jen, M Croucher, L S Jen, S M Gentleman

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Eye and brain, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

H R WattsDepartment of Medicine, Imperial College London, Charing Cross Campus, London, UK.
Pjb AndersonDepartment of Medicine, Imperial College London, Charing Cross Campus, London, UK.
D MaDepartment of Surgery and Cancer, Imperial College London, Chelsea and Westminster Hospital, London, UK.
K L PhilpottNeurosciences, Centre of Excellence for Drug Discovery, GlaxoSmithKline Pharmaceuticals, Harlow, Essex, UK.
S M JenDepartment of Medicine, Imperial College London, Charing Cross Campus, London, UK.
M CroucherDepartment of Medicine, Imperial College London, Charing Cross Campus, London, UK.
L S JenDepartment of Medicine, Imperial College London, Charing Cross Campus, London, UK.
S M GentlemanDepartment of Medicine, Imperial College London, Charing Cross Campus, London, UK.
Charing Cross Hospital · GB

Funding

THE APOE-APP AXIS IN ALZHEIMER PATHOGENESISP01AG012411 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI GRIFFIN, SUE TILTON · 1995 to 2020
$25.0M
NIA NIH HHS P01 AG012411
6 · The paper itself

Abstract

The present study examined the relationship between amyloid beta (Aβ)-peptide aggregation state and neurotoxicity

Indexed as

Alzheimer diseaseretina

Identifiers

PMID28539771
PMCPMC5436173
OpenAlexW1995240582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.